Retrospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Sep 7, 2015; 21(33): 9765-9773
Published online Sep 7, 2015. doi: 10.3748/wjg.v21.i33.9765
Figure 1
Figure 1 Pretreatment serum CXCL 10 levels according to patient characteristics. A: Serum CXCL 10 levels between PegIFNα-2a/RBV induced TD vs NTD; B: Serum CXCL 10 levels between TPOAb (+) and TPOAb (-). TD: Thyroid dysfunction; NTD: Non-thyroid dysfunction; PegIFNα-2a/RBV: Peginterferon alfa-2a/ribavirin.